Earl Albone

Earl Albone is an accomplished Executive Biopharmaceutical Scientist and Consultant specializing in bioanalysis, DMPK, and translational strategy for biologics and ADC programs. They have held leadership roles at prominent companies, including Morphotek, Inc. and BioRexis Pharmaceutical Corp, where they drove significant advancements in biochemistry and immunotherapeutics. Earl is currently a consultant at GrangeBio Consulting, LLC and as Head of Discovery at Code Biotherapeutics, continues to lead innovative developments in DNA-based nanoparticle platforms. They earned a PhD in Biochemistry from the University of Rochester School of Medicine and Dentistry.